Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Gilead Sciences, Raises Price Target to $65

Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and raises the price target from $63 to $65.
byBenzinga Newsdesk
July 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and raises the price target from $63 to $65.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

SharkNinja Emerges As A Strong Buy: Analyst Forecasts Growth Amid Strategic Innovations

By Shivani Kumaresan
May 16, 1:26 PM
BofA Securities' Alexander Perry initiated coverage on SharkNinja with a Buy rating and a $90.00 price target. Perry highlighted the company's robust growth potential, driven by its data-driven innovation and market expansion. SharkNinja's plans to launch 25 new products annually, along with expanding shelf space at major retailers like Amazon, Walmart, and Costco, are expected to bolster its market share.

AMZN